Solvent-detergent plasma: Use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies

Transfusion Medicine

Volumn 16, Issue 2, 2006, Pages 85-91

  Chekrizova, V ^a   Murphy, W G ^a  

^a National Blood Centre Ireland   (Ireland)

Author keywords

Coagulopathy; Gynaecological obstetric emergencies; Liver disease; Neonates; SD plasma

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 8; DETERGENT; FIBRINOGEN; IMMUNOGLOBULIN; SOLVENT;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; EMERGENCY TREATMENT; FEMALE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PARTIAL THROMBOPLASTIN TIME; PLASMA; PROTHROMBIN TIME; TREATMENT OUTCOME; ADOLESCENT; AGED; BLOOD COMPONENT THERAPY; CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; INFANT; LIVER TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; MORTALITY; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COMPONENT TRANSFUSION; DETERGENTS; DISSEMINATED INTRAVASCULAR COAGULATION; EMERGENCY MEDICAL SERVICES; FEMALE; HEMORRHAGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PLASMA; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; SOLVENTS;

EID: 33745001461     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2006.00626.x     Document Type: Article

References (24)

1. Alford B.L. ( 2002) Important new drug warning. Available at: http://www.fda.gov/medwatch/SAFETY/2002/plassd_deardoc.pdf.
2. Aronis S. Platokouki H. Photopoulos S. Adamtziki E. Xanthou M. ( 1998) Indications of coagulation and/or fibrinolysis system activation in healthy and sick very-low-birth-weight neonates. Biology of the Neonate, 74, 337 344.
3. Beck K.H. Mortelmans Y. Kretschmer V. ( 1994) Protocol and preliminary results of a clinical study for comparison of solvent/detergent-inactivated plasma VIP versus FFP with special consideration of the balance of haemostasis. Beitrage zur Infusionstherapie und Transfusionsmedizin, 32, 440 444.
4. British Committee for Standards in Haematology. ( 2004) Guidelines for the use of fresh frozen plasma, cryoprecipitate and cryosupernatant. British Journal of Haematolology, 126, 11 28.
5. de Jonge J. Groenland T.H. Metselaar H.J. Ijzermans J.N.M. van Vliet H.H.D.M. Visser L. Tilanus H.W. ( 2002) Fibrinolysis during liver transplantation is enhanced by using solvent/detergent-treated plasma (ESDEP). Anesthesia and Analgesia, 94, 1127 1131.
6. Flesland O. Seghatchian J. Solheim B.G. ( 2003) The Norwegian plasma fractionation project - a 12 years clinical and economic success story. Transfusion and Apheresis Science, 28, 93 100.
7. Harney M.S. Ghani A.C. Donnelly C.A. Walsh R.Mc. Walsh M. Howley R. Brett F. Farrell M. ( 2003) vCJD risk in the Republic of Ireland. BMC Infectious Diseases, 3, 28 (retrieved from http://www.biomedcentral.com/1471-2334/3/28).
8. Haubelt H. Blome M. Kiessling A.H. Isgro F. Bach J. Saggau W. Hellstern P. ( 2002) Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery. Vox Sanguinis, 82, 9 14.
9. Hellstern P. ( 2004) Solvent/detergent treated plasma: composition, efficacy, and safety. Current Opinion in Hematology, 11, 346 350.
10. Hellstern P. Larbig E. Walz G.A. Thurigen W. Oberfrank K. ( 1993) Prospective study on efficacy and tolerability of solvent/detergent-treated plasma in intensive care unit patients. Infusionstherapie und Transfusionsmedizin, 20 ( Suppl. 2 16 18.
11. Hellstern P. Muntean W. Schramm W. Seifried E. Solheim B.G. ( 2002) Practical guidelines for the clinical use of plasma. Thrombosis Research, 107 ( Suppl. 1 53 57.
12. Horowitz B. Bonomo R. Prince A.R.M. Chin S.N. Brotman B. Schulman R.W. ( 1992) Solvent/detergent-treated plasma, a virus-inactivated substitute for fresh frozen plasma. Blood, 79, 826 831.
13. Horowitz M.S. Pehta J.C. ( 1998) SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sanguinis, 74 ( Suppl. 1 231 235.
14. Hyytiainen S. Syrjala M. Fellman V. Heikinheimo M. Petaja J. ( 2003) Fresh frozen plasma reduces thrombin formation in newborn infants. Journal of Thrombosis and Haemostasis, 1, 1189 1194.
15. Inbal A. Epstein O. Blickstein D. Kornbrot N. Brenner B. Martinowitz U. ( 1993) Evaluation of solvent/detergent-treated plasma in the management of patients with hereditary and acquired coagulation disorders. Blood coagulation and fibrinolysis, 4, 599 604.
16. Koenigbauer U.F. Eastlund T. Day J.W. ( 2000) Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma. Transfusion, 40, 1203 1206.
17. Lerner R.G. Nelson J. Sorcia E. Grima K. Kancherla R.R. Zarou-Naimo C.M. Pehta J.C. ( 2000) Evaluation of solvent/detergent-treated plasma in patients with a prolonged prothrombin time. Vox Sanguinis, 79, 161 167.
18. Marshall J.C. Cook D.J. Christou N.V. Bernard G.R. Sprung C.L. Sibbald W.J. ( 1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Critical Care Medicine, 23, 1638 1652.
19. Noddeland H. Tollofsrud S. Svennevig J. Bentsen G. Brosstad F. ( 2002) Universal solvent/detergent-treated fresh frozen plasma (Uniplas) - rationale and clinical properties. Thrombosis Research, 107 ( Suppl. 1 S33 S37.
20. Pollack M.M. Patel K. Ruttiman U. ( 1996) PRISMIII: an updated pediatric risk of mortality score. Critical Care Medicine, 24, 743 752.
21. Solheim B.G. Rollag H. Svennevig J.L. Arafa O. Fosse E. Bergerud U. ( 2000) Viral safety of solvent/detergent-treated plasma. Transfusion, 40, 84 90.
22. Stanworth S.J. Brunskill S.J. Hyde C.J. McClelland D.B.L. Murphy M.F. ( 2004) Is fresh frozen plasma clinically effective? A systematic review of randomised clinical trials. British Journal of Haematology, 126, 139 152.
23. Tollofsrud S. Noddeland H. Svennevig J.L. Bentsen G. Mollnes T.E. Solheim B.G. ( 2003) Universal fresh frozen plasma (Uniplas): a safe product in open-heart surgery. Intensive Care Medicine, 29, 1736 1743.
24. Williamson L.M. Llewelyn C.A. Fisher N.C. Allain J.P. Bellamy M.C. Baglin T.P. Klinck J.R. Ala F.A. Smith N. Neuberger J. Wreghitt T.G. ( 1999) A randomised trial of solvent/detergent and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion, 39, 1227 1234.